How Amylyx Pharmaceuticals makes money

Period

FY2024

How does Amylyx Pharmaceuticals make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Amylyx Pharmaceuticals Inc. · FY2024 · year ended 2024-12-31

Revenue$87MNet loss$302M · 345%Cost of revenue$6M · 7%Gross profit$81M · 93%Operating expenses$396M · 453%Other income$13M · 15%R&D$104M · 119%SG&A$114M · 131%Other opex$178M · 203%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.